ציפרוקסין 200

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

CIPROFLOXACIN AS LACTATE 0.2 G / 100 ML

MAH:

BAYER ISRAEL LTD

ATC_code:

J01MA02

pharmaceutical_form:

SOLUTION FOR INFUSION

administration_route:

I.V

manufactured_by:

BAYER PHARMA AG, GERMANY

therapeutic_group:

CIPROFLOXACIN

therapeutic_indication:

Adults:Uncomplicated and complicated infections caused by ciprofloxacin sensitive pathogens.Children: For the treatment of acute pulmonary exacerbation of cystic fibrosis associated with Pseudomonas aeroginosa infections in pediatric patients aged 5-17 years.

authorization_date:

2010-08-01